PTIX - Protagenic Therapeutics logo

PTIX

Protagenic Therapeutics

Net โ€”top 1%Rev โ€”top 1%10Y
Hold

Protagenic Therapeutics develops peptide-based medicines derived from cannabinoids and natural brain hormones to treat stress-related and central nervous system disorders, focusing on innovative therapeutics for mood and mental health conditions.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 20 years ago โ†’$114today

Score Overview

1 Year
Scoreโ€”
Net Growth6.67%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-102.31%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistency
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistency
All Time
Scoreโ€”
Net Growth-126.55%
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

Protagenic Therapeutics fundamental performance

Across Protagenic Therapeutics's full reported history, from 2016 to 2025, net income went from -$ 2M to -$ 5M. Revenue increased in 0% of the years measured; net income in 44%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-11
$ 0.32โ€”
1 Year2025-08-12
$ 2.75-88.36%
5 Years2021-08-12
$ 108.08-99.70%
10 Years2016-07-26
$ 0.0311x
20 Years2006-05-08
$ 2.80-88.57%
All Time2016-01-05
$ 0.0128x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025-$ 5M$ 2M
2024$ 0.00-$ 5M$ 1M
2023$ 0.00-$ 5M$ 4M
2022$ 0.00-$ 3M$ 7M
2021$ 0.00-$ 4M$ 10M
2020$ 0.00-$ 2M$ 671.09K
2019$ 0.00-$ 1M$ 798.62K
2018$ 0.00-$ 2M$ 612.87K
2017$ 0.00-$ 2M$ 1M
IPO2016$ 0.00-$ 2M$ 3M

Explore beyond PTIX

You're looking at Protagenic Therapeutics. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies